Arne Östman

Active 1987–2025

102
Papers
22,359
Citations
79
h-index
102
i10-index

Citations

Citations per year for Arne Östman1926: 1 citations1969: 2 citations1987: 5 citations1988: 21 citations1989: 77 citations1990: 69 citations1991: 46 citations1992: 55 citations1993: 46 citations1994: 38 citations1995: 31 citations1996: 28 citations1997: 16 citations1998: 17 citations1999: 47 citations2000: 48 citations2001: 77 citations2002: 96 citations2003: 161 citations2004: 224 citations2005: 182 citations2006: 171 citations2007: 186 citations2008: 214 citations2009: 189 citations2010: 269 citations2011: 215 citations2012: 256 citations2013: 257 citations2014: 322 citations2015: 211 citations2016: 228 citations2017: 259 citations2018: 223 citations2019: 595 citations2020: 654 citations2021: 684 citations2022: 567 citations2023: 354 citations2024: 579 citations2025: 290 citations2026: 6 citations1927–1968: no citations, so these years are not shown1970–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,353 citing papers, 25.6% of this breakdownChina: 1,337 citing papers, 14.6% of this breakdownSweden: 568 citing papers, 6.2% of this breakdownGermany: 518 citing papers, 5.6% of this breakdownUnited Kingdom: 486 citing papers, 5.3% of this breakdownItaly: 331 citing papers, 3.6% of this breakdownCanada: 315 citing papers, 3.4% of this breakdownJapan: 283 citing papers, 3.1% of this breakdownFrance: 272 citing papers, 3% of this breakdownAustralia: 213 citing papers, 2.3% of this breakdownNetherlands: 184 citing papers, 2% of this breakdownSwitzerland: 182 citing papers, 2% of this breakdown
0%25.6%Other 23.3%

Fields

  • Biochemistry, Genetics and Molecular Biology40.8%
  • Medicine40.6%
  • Immunology and Microbiology4.8%
  • Engineering4%
  • Materials Science3.2%
  • Neuroscience3.2%
  • Other3.4%

Topics

  • Cancer Cells and Metastasis4.5%
  • Cancer, Hypoxia, and Metabolism2.9%
  • Angiogenesis and VEGF in Cancer2.6%
  • Immune cells in cancer2.3%
  • Advanced biosensing and bioanalysis techniques2.3%
  • Nanoplatforms for cancer theranostics1.8%
  • Other83.6%

Coauthors

All papers

Open in search
  1. High interstitial fluid pressure — an obstacle in cancer therapy

    Authors: , , , - Nature reviews. Cancer 2004 cited by 2,175

  2. Protein detection using proximity-dependent DNA ligation assays

    Authors: , , , , , , , - Nature Biotechnology 2002 cited by 1,533

  3. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth

    Authors: , , , , , , , , , , , , - eLife 2020 cited by 203

  4. Hallmarks of cancer: Interactions with the tumor stroma

    Authors: , - Experimental Cell Research 2010 cited by 1,139

  5. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 243

  6. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features

    Authors: , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2022 cited by 66

  7. Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ

    Authors: , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2018 cited by 152

  8. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 113

  9. Protein-tyrosine phosphatases and cancer

    Authors: , , - Nature reviews. Cancer 2006 cited by 662

  10. Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2017 cited by 211

  11. Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells

    Authors: , , , , , , , , - Cell Death Discovery 2020 cited by 103

  12. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall

    Authors: , , , , , , , , , , , , , , - Genes & Development 2003 cited by 659

  13. Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties

    Authors: , , , , , , , - Cancer Research 2014 cited by 170

  14. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death

    Authors: , , , , , , , , - Cell Death and Disease 2017 cited by 112

  15. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer

    Authors: , , , , , , , , , , , , , , - Science Advances 2019 cited by 130

  16. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 241

  17. STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Research 2012 cited by 177

  18. Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15

    Authors: , , , , , , , , , , , , - Cancer Research 2014 cited by 124

  19. VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells

    Authors: , , , , , , , , , , , , , , , - Cell Reports 2023 cited by 31

  20. Astrocytes enhance glioblastoma growth

    Authors: , , , , , , , , , , , , - Glia 2019 cited by 103

  21. Signal transduction via platelet-derived growth factor receptors

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1998 cited by 736

  22. Regulation of protein tyrosine phosphatases by reversible oxidation

    Authors: , , , - The Journal of Biochemistry 2011 cited by 286

  23. Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer

    Authors: , , , , , , , , , - American Journal Of Pathology 2009 cited by 270

  24. Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase–Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells

    Authors: , , , , , , , - Molecular Cancer Research 2012 cited by 121